domingo, 22 de septiembre de 2013

Plateau effect of prostate cancer risk-associated S... [Prostate. 2013] - PubMed - NCBI

Plateau effect of prostate cancer risk-associated S... [Prostate. 2013] - PubMed - NCBI

Prostate. 2013 Aug 26. doi: 10.1002/pros.22721. [Epub ahead of print]

Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes.


Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China.



Additional prostate cancer (PCa) risk-associated single nucleotide polymorphisms (SNPs) continue to be identified. It is unclear whether addition of newly identified SNPs improves the discriminative performance of biopsy outcomes over previously established SNPs.


A total of 667 consecutive patients that underwent prostate biopsy for detection of PCa at Huashan Hospital and Changhai Hospital, Shanghai, China were recruited. Genetic scores were calculated for each patient using various combinations of 29 PCa risk-associated SNPs. Performance of these genetic scores for discriminating prostate biopsy outcomes were compared using the area under a receiver operating characteristic curve (AUC).


The discriminative performance of genetic score derived from a panel of all 29 SNPs (24 previous and 5 new) was similar to that derived from the 24 previously established SNPs, the AUC of which were 0.60 and 0.61, respectively (P = 0.72). When SNPs with the strongest effect on PCa risk (ranked based on contribution to the total genetic variance from an external study) were sequentially added to the models for calculating genetic score, the AUC gradually increased and peaked at 0.62 with the top 13 strongest SNPs. Under the 13-SNP model, the PCa detection rate was 21.52%, 36.74%, and 51.98%, respectively for men with low (<0 .5="" and="" high="" intermediate="">1.5) genetic score, P-trend = 9.91 × 10-6 .


Genetic score based on PCa risk-associated SNPs implicated to date is a significant predictor of biopsy outcome. Additional small-effect PCa risk-associated SNPs to be discovered in the future are unlikely to further improve predictive performance. Prostate 9999: 1-12, 2013. © 2013 Wiley Periodicals, Inc.
© 2013 Wiley Periodicals, Inc.


AUC, ChinaPCa, SNPs, biopsy, genetic score, prostate
[PubMed - as supplied by publisher]

No hay comentarios:

Publicar un comentario